MCCA
ZBH icon

Mill Creek Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Mill Creek Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,195
Closed -$238K – 274
2024
Q2 		$238K Buy
2,195
+106
+5% +$12.5K 0.01% 228
2024
Q1 		$276K Hold
2,089
– – 0.01% 200
2023
Q4 		$254K Sell
2,089
-159
-7% -$17.7K 0.01% 206
2023
Q3 		$252K Hold
2,248
– – 0.01% 193
2023
Q2 		$327K Buy
2,248
+31
+1% +$4.21K 0.01% 179
2023
Q1 		$286K Sell
2,217
-10
-0.4% -$1.26K 0.01% 193
2022
Q4 		$284K Buy
+2,227
New +$258K 0.01% 184

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Mill Creek Capital Advisors's ZBH Position: Q3 2024 in Review

Mill Creek Capital Advisors sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 2,195 shares — an estimated $238K sold.

Mill Creek Capital Advisors first reported a position in ZBH in Q4 2022 and held it in 7 quarters. The position peaked at $327K in Q2 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Mill Creek Capital Advisors reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Mill Creek Capital Advisors sold 2,195 Zimmer Biomet shares in Q3 2024, an estimated $238K.
  • Mill Creek Capital Advisors first reported a position in Zimmer Biomet in Q4 2022 and held it in 7 quarters.
  • Mill Creek Capital Advisors's Zimmer Biomet position peaked at $327K in Q2 2023.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Mill Creek Capital Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.